Herein, the X-ray powder diffraction (XRPD) crystal structure of a new Sildenafil cocrystal is
reported, where resorcinol has been used as the coformer. The crystal structure has been …

The previously unreported crystal structure of (S)-Dapoxetine hydrochloride (DAPHCl), the
only active pharmaceutical ingredient specially developed for the treatment of premature …

Sildenafil is a drug used to treat erectile dysfunction and pulmonary arterial hypertension.
Because of poor aqueous solubility of the drug, the citrate salt, with improved solubility and …

Sildenafil, the active ingredient of the drug developed by Pfizer for the treatment of erectile
dysfunction was firstly synthesized in 1989 in the United Kingdom and since then it has …

New multicomponent solid forms of sildenafil have been discovered by means of a
combined virtual/experimental cocrystal screening. Coformer selection of candidates was …

Sildenafil citrate monohydrate, well known as Viagra®, is a drug for the treatment of erectile
dysfunction. Here we present the X-ray crystal structure of the sildenafil base …

(S)-α-Ethyl-2-oxo-1-pyrrolidineacetamide (trade name levetiracetam), a derivative of
piracetam, is used clinically as an add-on treatment for partial-onset seizures. In this study …

Sildenafil citrate was crystallized by various techniques aiming to determine the behavior
and factors affecting the crystal growth. There are only 2 types of sildenafil obtaining from …

Two novel co-crystals of naproxen (NPX) were designed and prepared at a stoichiometric
ratio of 1: 1, namely, naproxen–caprolactam (NPX–CPL) and naproxen–oxymatrine (NPX …

The crystal structure of a new zonisamide cocrystal, an anticonvulsant drug used to treat the
symptoms of epilepsy and Parkinson's disease, with ϵ-caprolactam is reported herein. The …